NovAliX expands cryo-electron microscopy (cryo-EM) capabilities for drug development offering

Expansion includes acquisition of novel, high-resolution cryo-electron microscope – with micro electron diffraction (microED) capabilities for solving protein and small molecule structures NovAliX will further develop cryo-EM service offerings for pharmaceutical industry NovAliX, a drug discovery-focused Contract Research Organization (CRO), Mehr

NovAliX appoints Dr. Jerome Guillemont as head of drug discovery, alongside two new directors

Founded in 2002 and based in Strasbourg, France, NovAliX is a drug discovery-focused CRO with several unique technologies. It employs 200 researchers, with capabilities combining chemistry and biophysics. NovAliX offers its clients original collaborative models and extensive services within the Mehr